ProPhase Labs, Inc. is holding a Special Meeting on November 24, 2025, focusing on a major strategic pivot into digital assets and urgent steps to maintain Nasdaq listing compliance. The Board unanimously recommends voting FOR all six proposals.
Nasdaq Compliance and Stock Structure: The company faces a December 22, 2025, deadline to regain the minimum $1.00 bid price. Proposal 4 grants the Board authority to execute a reverse stock split, up to 1-for-10, to avoid delisting. Furthermore, a separate amendment has already authorized the Board to conduct forward or reverse splits ranging fro
...